Diverticulitis patient care during the Covid-19 pandemic in Germany—a retrospective nationwide population-based cohort study - Takeaways - MDSpire

Diverticulitis patient care during the Covid-19 pandemic in Germany—a retrospective nationwide population-based cohort study

  • By

  • Konstantin L. Uttinger

  • Maximilian Brunotte

  • Johannes Diers

  • Johan Friso Lock

  • Boris Jansen-Winkeln

  • Daniel Seehofer

  • Christoph-Thomas Germer

  • Armin Wiegering

  • November 25, 2023

  • 0 min

Share

  • 1

    The COVID-19 pandemic led to significant changes in diverticulitis management in Germany, including postponed elective surgeries and reduced emergency visits.

  • 2

    During lockdowns, patients with diverticulitis presented with more severe cases, resulting in higher complication rates compared to pre-pandemic times.

  • 3

    A retrospective cohort study analyzed 991,579 patient records to assess the impact of COVID-19 on diverticulitis admissions and treatments in Germany.

  • 4

    Patients with complicated diverticulitis could safely postpone surgery, while those diagnosed with acute diverticulitis within 30 days of COVID-19 faced higher risks.

  • 5

    The study aimed to compare diverticulitis management during lockdowns with previous years, highlighting the pandemic's effects on patient care.

Original Source(s)

Diverticulitis patient care during the Covid-19 pandemic in Germany—a retrospective nationwide population-based cohort study

  • by Konstantin L. Uttinger, Maximilian Brunotte, Johannes Diers, Johan Friso Lock, Boris Jansen-Winkeln, Daniel Seehofer, Christoph-Thomas Germer, Armin Wiegering

  • November 25, 2023

Related Content

Shoulder MRI: Rethinking Findings

Routine imaging may detect age-related tendon changes that do not explain patient-reported shoulder pain.

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

Tenecteplase Fails to Boost EVT Outcomes

Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.